ITGAM and Sepsis: Targeting P-selectin glycoprotein ligand 1 (PSGL-1/CD162) and Mac-1 (CD11b/CD18), not only inhibits pulmonary recruitment of neutrophils but also reduces lung damage in sepsis (29, 30).